Want to learn more?
We are open to exploring industry collaborations and opportunities to co-develop SeekR therapeutic programs.
November 14, 2025
CTI Life Sciences Fund (CTI) has launched Oligon Therapeutics (OligonTx), a new biotechnology company pioneering RNA-based multi-targeting drugs as novel treatments
November 14, 2025
AI IN RESEARCH AND PHARMA section of AIMed25 in San Diego, CA
We are open to exploring industry collaborations and opportunities to co-develop SeekR therapeutic programs.
